此次体验活动的记者代表来自亚太、非洲、拉美、阿拉伯、中东欧等地区。Leion Hey2除实时翻译与可视化字幕外，还具备佩戴轻便、交互自然等特点，现 场吸引大批记者试戴后纷纷点赞，成为"模数世界"展区的明星产品。 转自：新华财经 9月29日，来自全球91个国家的记者代表团走进北京经开区"模数世界"展示空间，现场体验亮亮视野（LLVISION）消费级AR翻译眼镜Leion Hey2。凭借"连 续、及时、抬头"的实时翻译体验，AR翻译眼镜为跨语言交流场景提供了低打扰、可视化的最新选择。在为北京文化论坛、IASP世界大会独家提供AR翻译 技术服务之后，亮亮视野AR翻译眼镜逐渐成为北京文化科技新符号。 作为我国最早专注于AR眼镜领域的高科技企业，亮亮视野集中呈现了AR+AI领域的最新成果，为北京建设国际科技创新中心提供了可感知、可验证的样 本，代表AR领域"北京队"折射出中国在新质生产力上的加速突破。随着亮亮视野AR翻译眼镜频繁亮相外交、科技与文化舞台，这一"中国创造"既体现自主 技术实力，也正在连接不同文明、增进彼此理解，进一步提升中国文化的国际影响力与软实力。（邵群） 编辑：湛玮琦 "文化交流需要科技赋能，才能让理 ...

多轮会场实测显示，设备采用近眼显示技术，将字幕叠加于佩戴者视线前方，既不打断与对方的目光接 触，也不破坏自然观感，还可减少对同传耳机等传统听觉设备的依赖，已在海外课堂、跨语言会议、出 境旅行等场景中落地应用。业内观察人士指出，AR翻译眼镜正从"概念演示"走向大型国际会议"主会场 实战"，可作为传统同传耳机的低干扰补充方案，为跨语言交流提供"可视化同传字幕"。在严苛场景 下，本土AR+AI硬件表现出成熟稳定的性能，为北京建设国际科技创新中心提供了扎实的实践案例支 撑。 "文化交流需要科技赋能，才能让理解超越语言壁垒。"亮亮视野创始人兼CEO吴斐表示，AR翻译眼镜 是用科技打破语言壁垒，让世界的交流更高效、更自然、更平等，这与2025北京文化论坛主题非常契 合。亮亮视野愿与各国伙伴一道，将AR翻译眼镜从"沟通工具"升级为"文明互鉴的桥梁"，让文化科技 创新更好地造福人类。 Leion Hey2 是亮亮视野(LLVISION)推出的新一代消费级AR字幕翻译眼镜，它突破了AR眼镜在轻量、性 能与续航之间的"不可能三角"困境：整机仅 49 克；支持 100 余种语言，实时翻译延迟低于 500 毫秒； 单机续航可达 8 ...

Core Viewpoint - The article discusses the advancements in AR glasses, particularly the Leion Hey2 model, which combines optical technology, AI, and supply chain improvements to provide real-time translation, marking a potential "iPhone moment" for the AR industry [1]. Group 1: Market Context and Demand - Language barriers remain a significant challenge in global business and cultural exchange, with the translation pen market reaching hundreds of millions of dollars in 2023 [2]. - The AR glasses market is expected to see substantial growth, with global shipments projected to reach 553,000 units in 2024 and 2.956 million units by 2028, reflecting a compound annual growth rate of 50% [9]. Group 2: Technological Advancements - The Leion Hey2 AR glasses utilize a combination of augmented reality and AI to provide real-time translation, projecting translated text onto the lenses for seamless communication [5]. - The device features a significant improvement in battery life, achieving over 8 hours of continuous use, and can extend to 96 hours with a portable charging case [17]. - The Leion Hey2 employs advanced optical technologies, including single-lens dual-eye diffraction waveguide and Micro-LED display, achieving a peak brightness of 2500 nits, addressing previous issues of visibility in bright conditions [17]. Group 3: Competitive Landscape - The AR glasses industry is experiencing intense competition, with a growing number of brands and innovations, leading to a projected market of 286,000 units in China by 2024 [28]. - The supply chain advancements in China have significantly reduced production costs by over 30%, enabling more affordable pricing for AR glasses [25]. - The Leion Hey2 has been recognized for its innovative features, winning the UNESCO "Top Ten Global Technology Innovation Award" and participating in international exhibitions [23].

Core Insights - The global language services market is projected to reach $53.91 billion in 2024, increasing to $61.87 billion in 2025, and potentially exceeding $90.82 billion by 2029, with China's market expected to grow by 20% to approximately 198.2 billion RMB in 2024 [1][2]. Company Overview - Liangliang Vision, a Chinese AR company, has been actively entering the billion-dollar language services market, leveraging its 11 years of experience in augmented reality technology [1][3]. - The company has developed smart glasses that have been implemented in various B2B scenarios, including manufacturing, healthcare, security, and logistics [1][3]. Product Launch and Features - The company launched the Leion Hey2 AR translation glasses in Seoul, capable of real-time translation in over 100 languages within 0.5 seconds, targeting diverse scenarios such as international meetings and travel [2][5]. - The Leion Hey2 weighs 49 grams and can operate continuously for 8 hours, with a portable case extending its battery life to 96 hours, achieving a balance in the "lightweight-performance-endurance" triangle [7][9]. Market Strategy - Liangliang Vision aims to consolidate its leading position in the enterprise market while strategically expanding into the global consumer market with the Leion series [5]. - The company has received significant investment from various institutions and has established a strong market presence, holding approximately 60% of the professional AR device market share in China [3][4]. Technological Innovation - The company has accumulated over 270 AR-related patents, covering critical areas such as optical design and AI algorithms, creating a robust technological moat [9]. - The integration of AI capabilities into AR devices has enabled large-scale applications in sectors like healthcare and security, enhancing the overall user experience [9]. Future Outlook - The AR glasses market is expected to grow rapidly, with the potential for AR devices to become as ubiquitous as smartphones, driven by increasing demand for cross-language communication and smart assistant applications [9].

Market Overview - The A-share market is experiencing narrow fluctuations, with new consumption concepts performing well [4][9] - The overall market sentiment is neutral, with increased caution among investors following recent market rebounds [9] - The performance of various indices shows that the innovation growth sector is outperforming, while the hard technology sector is lagging [7][8] Valuation Metrics - As of now, the price-to-earnings (P/E) ratio for the Shanghai Composite Index is 14.71, which is at the 31.98% historical percentile, while the price-to-book (P/B) ratio is 1.33, at the 9.94% historical percentile [8] - The ChiNext Index has a P/E ratio of 31.26, at the 11.71% historical percentile, and a P/B ratio of 3.8, at the 20.64% historical percentile [8] Industry Dynamics - The new consumption sector, particularly in beauty care and IP economy, is gaining traction, driven by rising consumer spending and cultural consumption awareness among the Z generation [9][10] - The precious metals sector is also seeing significant gains, with gold reserves reported at 7,383 million ounces (approximately 2,296.37 tons), marking a month-on-month increase of 6,000 ounces (approximately 1.86 tons) [10] Company Updates - Kelong Pharmaceutical (002422.SZ) has received drug registration approval for its injectable product, which is expected to generate sales of 1.35 billion yuan in 2024 [30] - Dize Pharmaceutical (688192.SH) is set to present significant research advancements at the upcoming European Hematology Association (EHA) annual meeting [33] - Tongcheng New Materials (603650.SH) has signed a share transfer agreement to sell a 12% stake in its subsidiary for 36 million yuan, aimed at optimizing its asset structure [34] Economic and Policy Developments - The People's Bank of China has conducted a 1,193 billion yuan reverse repurchase operation, indicating ongoing liquidity management in the market [18] - The establishment of a domestic trade credit insurance co-insurance body aims to enhance the capacity of domestic trade insurance and support enterprises in expanding the domestic market [20] Upcoming Events - The Fourth China-Africa Economic and Trade Expo is taking place in Changsha, with a focus on enhancing economic cooperation between China and African nations [40]